Historical record - last NADAC effective date: 2/22/2017
Product Information
CEFPROZIL 250 MG TABLET is a generic product labeled by Aurobindo Pharma Limited, priced at $0.9938 per EA under NDC 65862006801. Its NADAC has been published 170 times since Nov 28, 2013.
FDA first approved this application on May 24, 2007. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
250 mg/1
Manufacturer
Aurobindo Pharma LimitedNDC
65862006801
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
2/22/2017
Active Ingredients
CEFPROZILApproval Type
Generic (ANDA)
FDA Application
ANDA065340FDA Approved
5/24/2007
TE Code
AB
On Market Since
5/24/2007
Price Statistics
The NADAC for CEFPROZIL 250 MG TABLET has been published 170 times since Nov 28, 2013, and over the history we have for it it has declined 17.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.9938 per EA |
|---|---|
| All-time high | $1.5445 (Feb 12, 2014) |
| All-time low | $0.7595 (Feb 17, 2016) |
| Median price | $0.8937 |
| Average price | $0.9305 |
| Largest weekly change | +55.8% (Jan 22, 2014) |
| Weeks tracked | 170 |
| Tracking since | Nov 28, 2013 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
-17.6%
Last surveyed Feb 22, 2017 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 51% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of CEFPROZIL 250 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for CEFPROZIL 250 MG TABLET, manufactured by Aurobindo Pharma Limited, is $0.9938 per EA (NDC 65862006801), effective Feb 22, 2017.
How has the price of CEFPROZIL 250 MG TABLET changed over time?
Over the history we have for it, the NADAC for CEFPROZIL 250 MG TABLET has declined 17.6%. It has been tracked across 170 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for CEFPROZIL 250 MG TABLET?
Since Nov 28, 2013, the NADAC for CEFPROZIL 250 MG TABLET has ranged from a low of $0.7595 (Feb 17, 2016) to a high of $1.5445 (Feb 12, 2014), with a median of $0.8937 per EA.
Are there cheaper alternatives to CEFPROZIL 250 MG TABLET?
Yes. 4 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, CEFPROZIL 250 MG TABLET, is $0.4854 per EA — about 51% below CEFPROZIL 250 MG TABLET.
Who manufactures CEFPROZIL 250 MG TABLET?
CEFPROZIL 250 MG TABLET (NDC 65862006801) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.